34.84
price down icon0.60%   -0.21
after-market Dopo l'orario di chiusura: 34.84
loading

Alkermes Plc Borsa (ALKS) Ultime notizie

pulisher
Apr 03, 2026

Alkermes Starts Phase 3 Program for Narcolepsy Drug Candidate Alixorexton - Sleep Review

Apr 03, 2026
pulisher
Apr 02, 2026

Craig Hopkinson Sells 9,000 Shares of Alkermes (NASDAQ:ALKS) Stock - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

ALKS Stock Price, Quote & Chart | ALKERMES PLC (NASDAQ:ALKS) - ChartMill

Apr 02, 2026
pulisher
Apr 02, 2026

Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia - msn.com

Apr 02, 2026
pulisher
Apr 02, 2026

Top 2 Health Care Stocks That May Implode In April - Sahm

Apr 02, 2026
pulisher
Apr 01, 2026

Alkermes launches phase 3 trials for narcolepsy drug alixorexton By Investing.com - Investing.com Australia

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes stock hits 52-week high at $36.46 By Investing.com - Investing.com Canada

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes (ALKS) Advances Alixorexton into Phase 3 Trials for Nar - GuruFocus

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes (NASDAQ:ALKS) Sets New 1-Year HighStill a Buy? - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes stock hits 52-week high at $36.46 - Investing.com

Apr 01, 2026
pulisher
Apr 01, 2026

Lilly’s $7.8 Billion Bet Takes It Beyond Obesity Into Sleep - Bloomberg.com

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes launches phase 3 trials for narcolepsy drug alixorexton - Investing.com

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 - Yahoo Finance

Apr 01, 2026
pulisher
Apr 01, 2026

Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market Interest - Insider Monkey

Apr 01, 2026
pulisher
Mar 31, 2026

10 Stocks Dominating Today’s Market Surge: ImmunityBio, Alkermes, and More - Insider Monkey

Mar 31, 2026
pulisher
Mar 31, 2026

Highs Report: What is the target price for Alkermes plc stockEntry Point & Technical Pattern Based Signals - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 31, 2026

Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy - BioWorld MedTech

Mar 31, 2026
pulisher
Mar 31, 2026

Alkermes Shares Surge 15% Following Lilly-Centessa Deal - intellectia.ai

Mar 31, 2026
pulisher
Mar 31, 2026

Alkermes’ Future: Critical Developments and Financial Outlook - timothysykes.com

Mar 31, 2026
pulisher
Mar 31, 2026

Alkermes (ALKS) Shares Surge by Nearly 18% in Market Rally - GuruFocus

Mar 31, 2026
pulisher
Mar 31, 2026

Alkermes PLC (ALKS) Shares Up 18.16% on Mar 31 - GuruFocus

Mar 31, 2026
pulisher
Mar 31, 2026

Alkermes (NASDAQ:ALKS) Shares Gap UpStill a Buy? - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga

Mar 31, 2026
pulisher
Mar 31, 2026

Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Insider Sell: Does Alkermes plc offer margin of safety2026 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 30, 2026

Bank Watch: Can Alkermes plc deliver consistent dividends2026 Big Picture & Low Risk High Win Rate Stock Picks - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Tudor Investment Corp ET AL Acquires New Position in Alkermes plc $ALKS - MarketBeat

Mar 30, 2026
pulisher
Mar 28, 2026

Trading Systems Reacting to (ALKS) Volatility - Stock Traders Daily

Mar 28, 2026
pulisher
Mar 27, 2026

Alkermes plc (NASDAQ: ALKS) AGM May 20, 2026 — CEO succession, proxy votes - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Why Is Alkermes (ALKS) Down 2.6% Since Last Earnings Report? - Yahoo Finance

Mar 27, 2026
pulisher
Mar 26, 2026

Vanguard realignment; no Alkermes (NASDAQ: ALKS) shares reported - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Alkermes (NASDAQ:ALKS) Stock Rating Upgraded by Truist Financial - MarketBeat

Mar 26, 2026
pulisher
Mar 25, 2026

US Stocks Recap: What is the target price for Alkermes plc stock2026 Closing Moves & Growth Focused Stock Reports - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

Alkermes PLC (ALKS) Trading 3.57% Higher on Mar 25 - GuruFocus

Mar 25, 2026
pulisher
Mar 24, 2026

Alkermes (ALKS): Piper Sandler Lowers Price Target, Maintains Ov - GuruFocus

Mar 24, 2026
pulisher
Mar 24, 2026

Piper Sandler Issues Pessimistic Forecast for Alkermes (NASDAQ:ALKS) Stock Price - MarketBeat

Mar 24, 2026
pulisher
Mar 23, 2026

Alkermes announces inaugural Alkermes Pathways APN Research Awards™ program - msn.com

Mar 23, 2026
pulisher
Mar 21, 2026

Alkermes plc stock launches inaugural research awards program amid biotech innovation push - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 21, 2026

If You Invested $1,000 in Alkermes Plc (ALKS) - Stock Titan

Mar 21, 2026
pulisher
Mar 21, 2026

Alkermes shares rise after revenue beat and upbeat outlook offsets earnings miss - MSN

Mar 21, 2026
pulisher
Mar 18, 2026

Big Picture: Can Alkermes plc stock outperform in a bear marketMarket Movers & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Alkermes Q4 2025 earnings preview - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Alkermes outlines $1.73B–$1.84B 2026 revenue target as Avadel acquisition expands commercial reach - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Alkermes plc (ALKS) Latest Stock News & Headlines - Yahoo Finance

Mar 17, 2026
pulisher
Mar 17, 2026

Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Layoff Watch: Does Alkermes plc offer margin of safety2026 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

Holocene Advisors LP Cuts Holdings in Alkermes plc $ALKS - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Alkermes appoints new CFO - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

How Alkermes Plc (ALKS) Affects Rotational Strategy Timing - Stock Traders Daily

Mar 17, 2026
pulisher
Mar 16, 2026

Farallon Capital Management LLC Has $624,000 Stock Holdings in Alkermes plc $ALKS - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Alkermes plc Stock (ISIN: IE00B56GVS15) Under Pressure After Avadel Acquisition—Wells Fargo Raises - AD HOC NEWS

Mar 16, 2026
pulisher
Mar 15, 2026

Alkermes plc $ALKS is Commodore Capital LP's 7th Largest Position - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Baker BROS. Advisors LP Boosts Holdings in Alkermes plc $ALKS - MarketBeat

Mar 15, 2026
RDY RDY
$13.32
price down icon 1.11%
$23.08
price down icon 0.17%
$131.60
price down icon 0.72%
RGC RGC
$30.80
price down icon 8.66%
$13.44
price down icon 1.39%
$564.81
price down icon 0.96%
Capitalizzazione:     |  Volume (24 ore):